Role of DAP12 in Innate and Adaptive Immune Responses
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
7-10
Author(s):
Naoko Aoki, Shoji Kimura and Zhou Xing
TNFα as Therapeutic Target: New Drugs, More Applications
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
1
Page:
377-392
Author(s):
A.M. Reimold
Clinical Significance of Pleiotropic Effects of Statins: Lipid Reduction and Beyond
Journal:
Current Medicinal Chemistry
Volume:
9
Page:
1831-1850
Author(s):
J. Auer, R. Berent, T. Weber and B. Eber
Oxidative Brain Damage by Peroxynitrite in Bacterial Meningitis: A Target for Adjunctive Therapy?
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
2
Page:
109-127
Author(s):
Stefan Kastenbauer, Uwe Koedel and Hans-Walter Pfister
The Treatment of Chronic Hepatitis C not Responding to Interferon
Journal:
Current Pharmaceutical Design
Volume:
8
Page:
967-975
Author(s):
Raffaele Cozzolongo, Renato Cupone and Onofrio G. Manghisi
The Evolving Therapy of Rheumatic Diseases, The Future is Now
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
2
Page:
1-11
Author(s):
Yasser El-Miedany
The Use of Radioactive Iodine in the Management of Hyperthyroidism in Children
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
255-264
Author(s):
Scott A. Rivkees
Nerve Growth Factor in Neurological and Non-Neurological Diseases: Basic Findings and Emerging Pharmacological Prospectives
Journal:
Current Pharmaceutical Design
Volume:
7
Page:
113-123
Author(s):
Luigi Aloe, Paola Tirassa and Luisa Bracci-Laudiero
Biologic Agents in the Treatment of Rheumatoid Arthritis
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
217-233
Author(s):
Boulos Haraoui, Vibeke Strand and Edward Keystone
Use of Recombinant Human Erythropoietin as an Antianemic and Performance Enhancing Drug
Journal:
Current Pharmaceutical Biotechnology
Volume:
1
Page:
11-31
Author(s):
W. Jelkmann